Definitive Contract 75A50119C00075
Award Date
9/30/19
Potential Completion Date
3/31/29
Potential Value
$256M
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for BAXTER CELL HARVEST services in year 6 of the contract, awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense. The contract has a ceiling value of $38,250,000.00 and was awarded on September 30, 2016, with an ultimate completion date of August 31, 2018. It is a Firm Fixed Price delivery order contract. Emergent Biodefense is a for-profit manufacturer of...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Elusys Therapeutics Inc., a self-certified small disadvantaged business and manufacturer of goods, for the delivery of ANTHIM (obiltoxaximab). The contract has a firm fixed price of $124,650,623.00 and a completion date of April 30, 2027. There is no set-aside designation for this contract. Elusys Therapeutics Inc. is a subsidiary of the...
This is a $652,738,368.00 definitive, firm-fixed-price federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Emergent Biosolutions Canada Inc. The contract is for the supply of VIGIV (Vaccinia Immune Globulin Intravenous) and associated services to support the Strategic National Stockpile. This is a follow-on to previous CDC contracts and was not set aside for small businesses. Major subcontractors include IQVIA Government Solutions Inc. for...
The U.S. Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $41,801,810.00 firm fixed-price delivery order contract to Emergent Biodefense Operations Lansing LLC, doing business as Emergent Biodefense, for the procurement of BioThrax (Anthrax Vaccine Adsorbed). This contract, which is not a set-aside, has an ultimate completion date of September 30, 2025. Emergent Biodefense is the prime contractor and manufacturer of BioThrax, the only...
This is a $748,857,151.46 firm fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit manufacturer, to develop and deliver the ACAM2000 smallpox (vaccinia) vaccine over a 10-year period. The contract was awarded on a sole-source basis as Emergent is the only FDA-licensed provider of ACAM2000. This contract does not have a set-aside...
This is a $1,403,362,669.10 cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Emergent Product Development Gaithersburg Inc., a for-profit limited liability company manufacturing medical countermeasures and pharmaceuticals. The contract, which has a period of performance through September 29, 2026, is for the development of filovirus treatments. Emergent has received over $1.3...
This is a purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Metabiologics, Inc., a for-profit manufacturer of goods. The contract is for the provision of recombinant vaccination, serum collection, and botulinum toxin type C, D, E, F, and G challenge services. The contract has a firm fixed price of $3,500.00 and a completion date of September 10, 2010. The contract was not set aside...
This is a $65,806,649.98 cost-plus-fixed-fee definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Biofactura Inc., a for-profit manufacturer located in Frederick, Maryland. The contract includes preclinical and manufacturing development activities such as cell line development, process development, non-clinical efficacy and safety studies, manufacturing, and clinical activities. The contract has an...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded an Other Transaction Agreement to Emergent Biosolutions Canada Inc. valued at $34.6 million to support the development of human immune globulin (COVID-HIG) manufactured from human plasma with antibodies to SARS-CoV-2. The contract aims to prevent coronavirus disease (COVID-19) through October 2022. Performance will take place at Emergent Biosolutions Canada Inc.'s facility in Ottawa,...
This is a $19,763,563.00 cost-plus-fixed-fee delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Emergent Manufacturing Operations Baltimore LLC, a for-profit limited liability company and manufacturer of goods registered in the System for Award Management (SAM). The contract is part of the Centers for Innovation in Advanced...